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Introduction
Pulmonary hypertension (PH) is a severe and progressive cardiopulmonary disease that eventually leads to right ventricular hypertrophy and failure [1] . Multiple signaling pathways are implicated in the pathogenesis of PH, but Ca 2+ metabolism disorder remains a vital factor in disease initiation [2] . Caveolae are invaginations of the plasma membrane, and caveolin-1 (Cav-1) is the anchoring protein, Cav-1 plays a key role in promoting cellular contraction, proliferation and migration [3, 4] . Cav-1 regulates Ca 2+ channel activity in pulmonary arteries (PAs) and causes Ca 2+ homeostasis disarrangement in disease states, which accelerates disease progression [5] . The structure of aortas is very similar to PAs, and previous studies suggested that circulating microparticles induce endothelial dysfunction in aortas by decreasing NO production during hypoxic pulmonary artery hypertension (PAH) rat [6] . Endothelial nitric oxide synthase (eNOS) was also down-regulated in aortas of hypoxic PH rats [7] . These results demonstrate that functional and structural changes in aortas occur during the pathological process of PH, but whether changes in the expression and function of aortic Cav-1, which are abundantly expressed in aorta smooth muscle cells (AoSMCs), occur is not known.
Caveolae are plasma membrane lipid-raft domains in endothelial and smooth muscle cells, Cav-1 is a 21-24-kDa transmembrane protein that is the primary functional protein with a well-defined region (82-101aa) aptly named the caveolin-scaffolding domain, Cav-1 binds various signaling molecules [4, 8] . Low compliance in PAs is the typical pathophysiological characteristic of PH. Excessive vascular cell proliferation and muscularization of small PAs impairs arterial compliance, which is caused by an increase in intracellular Ca 2+ concentration ([Ca 2+ ] i ) [1, 9, 10] . There are three types of Ca channels (ROCC) [9] .The classical transient receptor potential (TRPC) proteins are highly expressed in pulmonary arterial smooth muscle cells (PASMCs), TRPC1 and TRPC6 are also upregulated in the PAs of rats with PH. Previous studies indicated that Ca 2+ channel activity was increased in PH rats and patients with idiopathic pulmonary arterial hypertension (IPAH). Specifically, TRPC1 and TRPC6-mediated an increase in SOCC and ROCC expression, respectively [11, 12] . Cav-1 KO mice develop right ventricle hypertrophy and lung abnormalities [13, 14] , and PH patients exhibit reduced levels of Cav-1 in endothelial cells and total lung tissue [15] .
In contrast to the activity in endothelial cells, Cav-1 expression is increased and [Ca 2+ ]i regulation is altered in VSMCs of PH patients [16] . Cav-1 in human airway smooth muscle cells enhances the level of store-operated Ca 2+ entry (SOCE) [17] . Cav-1 in PASMCs plays a crucial role in [Ca 2+ ] i signaling, and its expression increases under conditions of PH. PH is closely related to the overproduction of Cav-1, and Cav-1 contributes to PA dysfunction and sclerosis, which is observed in the PASMCs of patients with IPAH or MCT-induced PH rats [18, 19] . Cav-1 expression and function in PH may be cell-specific, similarly to its effect in cancer, and promote and inhibit tumor progression [20] . However, the relationship between aortic Cav-1 and Ca 2+ channels in PH is not clear. Caveolae and Cav-1 in endothelial and smooth muscle cells are vital sites for various membrane receptors and Ca 2+ channels, which are closely associated with the sarcoplasmic/ endoplasmic reticulum (SR/ER). These proteins are also sites for Ca 2+ entry through ROCC or SOCC [21] . Cav-1 in PASMCs of IPAH patients significantly alters the activity of SOCE [19] . Cav-1 in rat VSMCs and mouse aorta is tyrosine phosphorylated by cAbl, which contributes to the regulation of Ang II responses [22] . Cholesterol depletion in caudal and basilar arteries impaired the vascular reactivity to endothelin-1 (ET-1) by reducing SOCE dependence on TRPC1 [23] . The caveolae structure is associated with TRPC6 expression in glomerular mesangial cells [24] . Cav-1 is linked to the regulation of Ca 2+ signaling pathways in PAs and aortas [25] , but the expression and function of Cav-1 and Ca 2+ channels in PH rats AoSMCs is poorly defined, and this relationship requires further exploration.
The present study investigated changes in caveolae and Cav-1 expression and the relationship to Ca 2+ channels using AoSMCs and tissue from the aortas of PH rats. Collectively, our data demonstrated that the appearance of caveolae and the expression of Cav-1 protein and mRNA increased significantly in PH rat aortas, but TRPC1 and TRPC6 expression levels, left ventricular systolic pressure (LVSP) and left ventricular mass index (LVMI) were not significantly altered; Cav-1 only influenced receptor-operated Ca 2+ entry (ROCE) activity.
Materials and Methods

Animal models of PH
Two different animal models of PH were used. The monocrotaline (MCT) model was established using a single intraperitoneal injection of MCT (50 mg/kg) into male Sprague-Dawley (SD) rats (140 -150 g). The chronic hypoxic (CH) model was developed and characterized as previously described [26, 27] . Adult agematched male SD rats (200 -250 g) were used as normal controls for all models of PH. All rats were housed under temperature-controlled conditions (24°C) and exposed to a normal diurnal cycle with food and water provided ad libitum. Animals were anesthetized with urethane (1 g/kg) three weeks post-modeling. LVSP and right ventricle systolic pressure (RVSP) were measured using pressure transducers (YPJ01; Chengyi; China). Rats were sacrificed by thoracotomy to dissect the heart and lungs en bloc for post-hemodynamic measurements. RV/LV+S and LV/RV+S ratios (RVMI and LVMI) were calculated as an index of RV or LV hypertrophy. The Animal Care and Use Committee of Fujian Medical University approved all procedures.
Transmission electron microscopy (TEM)
Isolated aortas were quickly divided into three sections, fixed with glutaraldehyde (3%) and paraformaldehyde (1.5%) in PBS (0.1 M, pH 7.2) for at least two hours and up to several days at 4°C to observe morphology and distribution of caveolae in AoSMCs. Semi-thin and ultra-thin sections were dyed with uranyl acetate and lead citrate to examine the distribution of caveolae using TEM (PHILIPS EM208). All experimental procedures were performed in a double-blinded manner.
Quantitative real-time RT-PCR
Total RNA was isolated from de-endothelialized aortas using the RNeasy Mini Kit (Qiagen, Valencia, CA), cDNA was synthesized using the iScript cDNA Synthesis Kit (DRR037A, Takara, Japan). Relative gene expression of Cav-1 was measured using the SYBR Green Real-Time PCR kit (Bio-Rad, Hercules, CA) (Roche, Germany). The following primers were used: Cav-1: CAGACGAGGTGAATGAGAAG (forward), TGCCGAAGATGGTAGACAG (reverse), TRPC1: CGTGCGACAAGGGTGACTAT (forward), ACAGCATTTCTCCCAAGCAC (reverse), and TRPC6: GAGAACATAGGCTATGTTCTGTATGGAGTC (forward), CGCATCATCCTCAATTTCCTGG (reverse). 18s was used as an endogenous reference: 18s: GTCTGTGATGCCCTTAGATG (forward), and AGCTTATGACCCGCACTTAC (reverse).
Western blot analysis
Standard SDS-PAGE electrophoresis (12% gels) with transfer to a PVDF membrane was used [26, 27] . Membranes were incubated overnight at 4°C with a polyclonal rabbit anti-Cav-1 (1:5000; Cell Signaling Technology), anti-TRPC1 or anti-TRPC6 (1:300; Abcam), or β-actin (1:5000; Cell Signaling Technology) antibodies. Membranes were incubated with secondary antibodies for 1 h at room temperature. Immunoreactive bands were detected using enhanced chemiluminescence (Pierce, Rockford, IL), and images were captured using the Gel Logic 200 image system (Kodak, New Haven, CT).
Isometric contraction
The aortas were separated, placed in a Krebs solution containing NaCl 118 mM, KCl 4.7 mM, MgCl 2
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© 2016 The Author(s). Published by S. Karger AG, Basel www.karger.com/cpb endothelium was disrupted as described previously [26, 27] . A pH of 7.4 (adjusted with NaOH) was maintained in solution at a temperature of 37°C bubbled with 95% O 2 , and 5% CO 2 . A strain gauge connected to a polygraph was used to measure isometric contractions. The resting tension was adjusted to 1 g. Arterial rings were exposed to KCl (60 mM) to reach maximum contraction and verify vascular activity, and phenylephrine (PE, 3 × 10
M) followed by acetylcholine (Ach, 10
M) to verify complete endothelium denudation, which is the conventional process of isometric contraction measurement, before formal experiments were performed.
Cell isolation and culture
AoSMCs were isolated and cultured as previously described [26, 27] . Briefly, rats were anesthetized with urethane (1 g/kg) and exsanguinated. The aortas were dissected and placed into an HBSS solution containing NaCl 130 mM, KCl 5 mM, MgCl 2 1.2 mM, HEPES 10 mM, glucose 10 mM, and CaCl 2 1.5 mM. The deendothelialized aortas were digested at 37°C for 40 min in reduced-Ca 2+ (20 μM) HBSS containing collagenase (Type I, 3500 U/ml), papain (19 U/ml), and bovine serum albumin (4 mg/ml). Cells were manually disrupted to homogeneity in Ca
2+
-free HBSS and placed in cell suspension on coverslips in Ham's F-12 culture medium (with L-glutamine) supplemented with 1% fetal calf serum, 0.1 mg/ml penicillin, and 100 U/ml of streptomycin. Cells were transiently (16~24 hours) grown at 37°C in 5% CO 2 in modular incubators (Billups-Rothenberg, Inc.).
Measurement of [Ca 2+ ] i Determinations of [Ca
2+
] i were published extensively [27] . Briefly, AoSMCs were incubated with 5 μM of the Ca ] i was calibrated as previously described [27] .
Chemicals and Drugs
All chemicals were obtained from Sigma (U.S.A.) unless otherwise indicated. Cell culture reagents, including Ham's F-12 culture medium and FBS, were obtained from GIBCO (Australia). Cav-1 Scaffolding Domain Peptide (CSD) was obtained from Merck Chemicals Co. (Germany). Fluo-3 AM was purchased from Enzo Life Sciences Intl (U.S.A.).
Statistical analysis
Data are expressed as the means ± SE, and statistical significance was determined using unpaired or paired Student's t-tests or ANOVA as appropriate. Differences were considered significant at P < 0.05, and curve fits were created using the Sigma Plot 11.0 software.
Results
The identification of a PH rat model CH-induced and MCT-treated rats exhibited obvious PH and right ventricular hypertrophy after 3 weeks of modeling. The testing and methods of developing the PH model were described previously [26, 27] . RVSP and RVMI increased dramatically (control: 26.4 ± 0.91 mmHg/25.9 ± 0.23%, n = 32; MCT: 99.5 ± 4.95 mmHg/62.8 ± 1.28%, n =21; CH: 65.4±1.93 mmHg/38.6 ± 0.78%, n = 22 p < 0.01) (Fig. 1A and D) . However, LVSP, LVMI, and heart rate exhibited no significant changes (control: 120.2 ± 5.08 mmHg/118.8 ± 4.01%/355.5 ± 7.06 beats/min, n = 15; MCT: 115.4 ± 5.05 mmHg/106.8 ± 4.75%/357.8 ± 11.24 beats/min, n = 12; CH: 122.3 ± 5.12 mmHg/115.3 ± 7.27%/349.1 ± 6.29 beats/min, n = 13) (Fig. 1B, C, E) .
Distribution of caveolae and caveolin-1 expression in aortas
We used TEM on arterial sections from control and PH rats to observe the distribution and cellular location of caveolae in AoSMCs. Caveolae were observed in the AoSMCs of all three groups, and they were more abundant and densely packed in the PH rats compared to controls (Fig. 2) . We also assessed Cav-1 expression levels using quantitative real-time PCR and Western blot analyses to verify these observations using other quantitative methods. Cav-1 protein and mRNA expression in isolated aortas of PH rats increased significantly (control: 0.62 ± 0.03/ 0.94 ± 0.09, n = 6; MCT: 0.94 ± 0.02, p < 0.01/1.66 ± 0.25, p<0.05,n=6; CH: 0.95 ± 0.02, p < 0.01/1.47 ± 0.17, p<0.05, n=5) ( Fig. 3A and B) , which suggests that caveolae number and Cav-1 expression in PH aortas increased. However, TRPC1 and TRPC6 protein and mRNA expression levels were not markedly altered (TRPC1-control: 1.07 ± 0.05/1.03 ± 0.18, n = 3; MCT: 1.04 ± 0.03/1.12 ± 0.15, n = 3; and CH: 1.04 ± 0.02/1.08 ± 0.22, n = 3; TRPC6-control: 1.04 ± 0.03/1.02 ± 0.15, n = 3; MCT: 1.09 ± 0.03/1.14 ± 0.16, n = 3; and CH: 1.08±0.1/1.09±0.13, n=3), which is consistent with the left ventricular hemodynamic results ( Fig. 3C and D) . Cell
VDCC was not correlated with caveolae in vitro
We pre-incubated aortic rings for 1 hour with 7 mM methyl-β-cyclodextrin (MβCD) to disrupt caveolae via cholesterol depletion to determine the contribution of caveolae in altering the vasoreactivity of the aortas during PH. MβCD did not inhibit KCl-induced contractions in control rats, which is mediated by VDCC [28] . Caveolae destruction also did not alter the vascular reactivity of KCl in PH (Fig. 4) . The percentage inhibitions of MβCD were -1.78 ± 2.43% (n = 12, control), -1.35 ± 1.24% (n = 15, MCT) and -1.26 ± 2.83% (n = 13, (A, B) Cav-1 protein and mRNA expression in isolated aortas from CON or PH rats (n = 6). Western blots are shown at the top; (C, D) TRPC protein and mRNA expression in isolated aortas from CON or PH rats (n = 3), Western blots are shown at the top; Using β-actin as internal reference, measured as normalized to GAPDH using qRT-PCR (ΔΔCt) (n = 6/3). 
Cholesterol depletion with MβCD inhibited agonist-induced aortic ring contraction
We measured ET-1 and PE-induced aortic ring contraction in vitro with and without the combined action of MβCD to further examine whether caveolae directly regulated Ca 2+ channel activity. ET-1 and PE were used because these agents are prototypical [29, 30] . We incubated aortic rings for 1 hour with moderate MβCD to specifically exhaust cholesterol of caveolae [31] and allow comparisons to agonists response. We demonstrated that MβCD significantly decreased PE-dependent vasoconstriction (Fig. 6A-G) , in addition to its inhibitory action in ET-1 (Fig. 5A-G) . The percentage inhibitions of ET-1 or PE-induced aortic contraction by MβCD were -26.78 ± 5.26% / -32.7 ± 2.21% (n = 13/12, control), -33.3 ± 5.43% / -33.1 ± 2.85% (n = 15/13, MCT) and -35.2 ± 3.52% /-30.1 ± 3.16% (n = 12/15, CH), **p < 0.01. Previous studies (including our own) demonstrated that ET-1 and PE-induced PA contractions and the MβCD inhibition ratios were increased in PH (Fig. 5/6I ). However, the inhibition was not significantly increased in the PH aortas. Cholesterol repletion that included a dose of cholesterol before the addition of MβCD in each bathing solution noticeably altered the inhibitory action of MβCD in control rats (Fig.  5/6C ). Collectively, these results confirmed the ability of caveolae to regulate the activity of SOCC and ROCC. Caveolae in aortas and PAs may exert different functional features in PH. [32, 33] . MβCD did not decrease CPAinduced vasoconstriction in control rats (Fig.  7) . We assessed the effect of CPA in PH aortas, and CPA did not up-regulate vascular reactivity and was not inhibited by MβCD compared to control rats. The percentage inhibitions of CPA-induced aortic contraction by MβCD were -3.3 ± 2.59% (n = 17, control), -2.8 ± 4.01% (n = 13, MCT) and -1.6 ± 3.14% (n = 12, CH), respectively.
ROCC, but not SOCC, is the relevant
Using a similar approach, evidence supports a close association between ROCC and caveolae, in contrast to VDCC and SOCC. 1-oleoyl-2-acetyl-sn-glycerol (OAG) is a membranepermeable DAG analog that specifically activates ROCE and enhances [Ca 2+ ] i [34, 35] . MβCD reduced the reactivity of OAG and the increased contractility of OAG noticeably enhanced MβCD inhibition in PH rats (Fig. 8A-G) . These data indicate that cholesterol depletion inhibited ROCC activity. Notably, the percentage inhibition was markedly increased in the aortas of PH rats. The percentage inhibitions of OAG-induced aortic contraction by MβCD were -45.4 ± 2.57% (n = 13, control), -57.3 ± 2.29% (n = 15, MCT) and -54.8 ± 1.99% (n = 14, CH), **p < 0.01 compared to MβCD; ##p<0.01 compared to CON. Thess results are consistent with previous findings in PAs.
Cav-1 regulated Ca
2+ channel activity in native AoSMCs We examined Ca 2+ influx levels induced by CPA or OAG in AoSMCs of control rats to further investigate the underlying ability of Cav-1 to modify Ca 2+ channel activity. Cells were pretreated with a negative control (DMSO) or Cav-1 scaffolding domain peptide (CSD). The CSD cell-penetrating peptide sequences mimic the intracellular actions of Cav-1 [36, 37] . We observed that the increased activity of Cav-1 significantly enhanced Ca 2+ transients from OAG (control: 449.3 ± 12.36 nM, n = 12; CSD: 794.6 ± 22.69 nM, n = 15, p < 0.01) (Fig. 9B, C) , but it failed to alter CPA-dependent Ca 2+ influx (control: 321.1 ± 11.74 nM, n = 15; CSD: 325.1 ± 6.55 nM, n = 15) (Fig. 9A, C) . Previous studies demonstrated that down-regulation of Cav-1 with siRNA or disruption of caveolae with MβCD attenuated SOCE in IPAH-PASMCs. Cav-1 was also increased in PASMCs of MCT-induced PH rats [18, 19] . Therefore, the inability of CSD to regulate SOCC in the aortas suggests that Ca 2+ channels exhibit a different functionality in aortas and PAs, at least partially via the different effects of caveolae and Cav-1.
Discussion
The present study used the caveolae-specific inhibitor MβCD and Cav-1 peptide to investigate the contribution of Cav-1 in altering vasoreactivity and Ca 2+ transients in the aortas of control and PH rats. This study presents the following primary findings: 1) caveolae number and Cav-1 expression are increased in the aortas of PH rats; 2) MβCD reduced OAGactivated aortic contraction, and the increased contractility of OAG noticeably enhanced the inhibition in PH rats; and 3) CSD significantly altered the Ca 2+ response elicited by OAG in AoSMCs. These results suggest that Cav-1 is associated specifically with ROCE in aortas. Our evaluation of the effect of Cav-1 in the aortas of PH rats suggests a different mechanism of pathogenesis in PAs and aortic diseases.
PH contributes to a gradual progression towards lung disease that is characterized by intensive vascular tone, excessive vascular cell proliferation, profound vascular remodeling, and vaso-obliteration, which results in a high morbidity and mortality rate [1, [38] [39] [40] [41] . Caveolae and Cav-1 are distributed ubiquitously in the vasculature, and Cav-1 is a regulatory molecule implicated in the pathogenesis of cardiovascular diseases, such as atherosclerosis [42] , atrial fibrillation [43] , hypertension and PH [25] . The expression and effect of Cav-1 in PH patients and animal models are a result of polymorphisms. The main signs are a reduction in Cav-1 in endothelial cells and lung tissue, but an elevation in the number of VSMCs [13, 44] . Caveolae distribution and Cav-1 expression are dramatically increased in PASMCs in clinical settings and experimental PH [15, 16] . Cav-1 and caveolae expression is increased in VSMCs and contributes to the pathophysiology of IPAH. It is crucial for Ca 2+ entry through Ca 2+ channels [19, 45] . The endothelial function of rat aortas is inhibited by perivascular adipose tissue via Cav-1 [46] . Disruption of caveolae inhibited TRPC6 activity in bovine aortic endothelial cells [47] . The present study demonstrated an up-regulation of Cav-1 expression in the aortas of PH rats. The ventricular systolic pressure (VSP), ventricular mass index (VMI), and heart rates are commonly used as indicators to assess systolic and diastolic function. However, in contrast to enhanced RVSP and RVMI, LVSP and LVMI, TRPC1 and TRPC6 expression, which mediate SOCC and ROCC, exhibited no change in the aortas of PH rats. This result questions the functional relevance of Cav-1 in PAs and the aortas of PH rats.
Intracellular Ca 2+ is a critical secondary messenger, and it regulates various physiological and pathophysiological activities in cells [48] . Disruption of homeostatic Ca 2+ within PASMCs was a vital triggering factor in the pathogenesis of PH [2, 49] . ] i regulation. However, the former channels are a major contributor to [Ca 2+ ] i elevation and the increased expression of SOCC and ROCC in PH PAs [50, 51] . The TRPC proteins are generously expressed in PASMCs and PAs, and TRPC1 and TRPC6 are upregulated in PAs of PH rats. Previous studies (including our own) demonstrated that Cav-1 regulated SOCC activity in PASMCs [19] . The regulatory effect was also more pronounced in PH rats, which is consistent with enhanced Cav-1 expression. Cav-1 is an important regulator of AoSMCs proliferation, migration, and Ca 2+ response to vasoactive factor [52] . The significant enhancement of Cav-1 in PH rats prompted further exploration of the relationship between Cav-1 and different Ca 2+ channels in PH aortas. Our experiments used five different vasoconstrictors: KCl, PE, ET-1, CPA, and OAG. ET-1 and PE activate the SOCC and ROCC in VSMCs. ET-1 is an effective vasoconstrictor with unique physiological significance [28, 29] . CPA and OAG are specific agonists of SOCC and ROCC, respectively, and SOCC and ROCC play vital roles in the occurrence and development of PH [49] . This study clearly demonstrated that caveolae contributed to PE, ET-1, and OAGinduced aortic vasoreactivity, but KCl and CPA had no effect. Notably, ET-1 or PE-activated aortic reactivity and inhibition of MβCD were not altered in PH rats. In contrast, OAG-induced vasoconstriction was significantly enhanced in the aortas of PH rats, and the increased contractility of OAG noticeably enhanced the inhibition of MβCD. These data indicated that destruction of the caveolae structure in aortas via cholesterol depletion directly inhibited ROCC activity. However, SOCC and VDCC activity was not affected, and therefore, SOCC, VDCC, and caveolae may not be closely related in AoSMCs. We conclude that ROCC is closely related to caveolae in PAs and aortas.
Cav-1 binds numerous signaling proteins that are concentrated in caveolae or intracellular organelles, where Cav-1 is also expressed. The Cav-1 scaffolding domain mediates the binding of Cav-1 to other signaling proteins [4, 8, 53] . Cav-1 plays a vital role in regulating Ca 2+ entry pathways in the plasma membrane. Up-regulated Cav-1 expression levels aggravate high-salt diet-induced endothelial dysfunction and hypertension in type 1 diabetic rats [54] . We investigated Ca 2+ influx levels induced by CPA or OAG in AoSMCs to further examine the underlying ability of Cav-1 to modify SOCC or ROCC activity. We used a Cav-1 peptide to better investigate the relationship between Cav-1 and Ca 2+ channels and observed that Cav-1 activity altered by the Cav-1 peptide, significantly influenced Ca 2+ transients from OAG, but not from CPA. Collectively, these data confirm the functional ability of Cav-1 to regulate ROCC, but not SOCC, activity in AoSMCs, which may explain the differential mechanism of pathology in PAs and aortas diseases.
A rise in VSMC [Ca 2+ ] i is a major pathogenic factor in cardiovascular function [10, 14] . Cav-1 is expressed in cardiac myocytes similarly to the pulmonary vasculature. Cav-1 KO mice developed severe heart fibrosis, decreased endothelial cell proliferation and increased apoptosis [55, 56] . Cav-1 is a negative regulator of reactive oxygen species derived from NADPH oxidase and inhibits eNOS activity and endothelium-dependent relaxation in endothelial cells [4, 57] . The introduction of Cav-1 peptide inhibits tumor progression, but the loss of Cav-1 induces oncogenic transformation [20, 58] . Therefore, Cav-1 plays a negative and positive role in different phases of cancer progression. The effect of Cav-1 is cell specific, but it plays a significant role in the modulation of cardiovascular diseases. Cav-1 is an important regulatory protein of [Ca 2+ ] i , and it facilitates Ca 2+ mobilization, enhances vascular reactivity to agonists, and contributes to myogenic tone in arteries [17, 18, 21, 59] . Therefore, Cav-1 also plays a cell-specific dual role in PH progression.
Previous PH research primarily focused on Ca 2+ channels in PAs with little exploration into functional changes in aortas. Previous studies demonstrated that the primary function of Ca 2+ channels in the pathogenesis of PH was dependent on ROCC and SOCC, despite the fact that VDCC is the main contributor to hypertension [27, 49, 60] . This study used AoSMCs and tissue to investigate aspects of organization and cell function, and we observed that the function of ROCC may be affected by up-regulated caveolae and Cav-1 during PH progression. Analyzing these Ca 2+ channels functions are important to further clarify the pathogenesis of PH. However, the development of PH is associated with a broad spectrum of diseases of different etiologies [40, [61] [62] [63] . The specific mechanism is not well understood, and two PH rat models were used instead of patients in our study. Therefore, further studies are warranted to define the potential pathogenic effects of ROCC and SOCC in PH patients and hypertensive rats.
In conclusion, our study used two PH rat models to evaluate the effect of Cav-1 and the resulting changes in different Ca 2+ channels in the aortas of PH rats. We found that the number of caveolae and Cav-1 expression level in PH aortas increased. Furthermore, Cav-1 contributed to an OAG-mediated aortic contraction that was enhanced significantly in CH and MCT-induced PH rats, and the increased contractility of OAG markedly enhanced the inhibition of MβCD. TRPC6 expression was not altered. We hypothesize that the upregulation of caveolae and Cav-1 may affect the function of ROCC. However, further studies are necessary to determine the specific disease mechanism and investigate the effect of Cav-1 and different Ca 2+ channels in PH patients and aortic diseases in animal models.
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